StonvexLoading…
StonvexCore line items from GBX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-08-31 | Annual 2023 2023-08-31 | Annual 2022 2022-08-31 |
|---|---|---|---|---|
Revenue | $3.24B | $3.54B | $3.94B | $2.98B |
Operating Income | $360.10M | $324.50M | $176.40M | $118.00M |
Net Income | $204.10M | $160.10M | $62.50M | $46.90M |
EPS (Diluted) | $6.35 | $4.96 | $1.89 | $1.40 |
Total Assets | $4.36B | $4.25B | $3.98B | $3.85B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $306.10M | $351.80M | $281.70M | $543.00M |
Free Cash Flow OCF − CapEx | $-14.70M | $-68.70M | $-290.90M | $-531.10M |
Shares Outstanding | 30.87M | 31.14M | 30.88M | 32.60M |